Management of Rare Adult Tumours

  • Yazid Belkacémi
  • René-Olivier Mirimanoff
  • Mahmut Ozsahin

Table of contents

  1. Front Matter
    Pages I-4
  2. CNS tumors

    1. Front Matter
      Pages 5-5
    2. D. Pasquier, N. Rezvoy
      Pages 19-27
    3. Ph. M. P. Poortmans
      Pages 29-40
    4. N. Penel, C. Ferte, É. Le Rhun, Y. Belkacémi
      Pages 41-44
    5. D. C. Weber
      Pages 45-50
    6. A. Pica, R.-O. Mirimanoff
      Pages 51-56
    7. V. Monnard, R.-O. Mirimanoff
      Pages 57-63
  3. Heads and neck tumors

    1. Front Matter
      Pages 65-65
    2. O. Matzinger
      Pages 67-72
    3. E. Özyar, M. Gültekin
      Pages 87-95
    4. C. Ikonomidis, L. Bron
      Pages 105-115
    5. G. Ugurluer, A. Zouhair, M. Ozsahin
      Pages 117-122
    6. Y. Anacak, S. Kamer
      Pages 123-126
  4. Gastro-intestinal tumors

    1. Front Matter
      Pages 127-127
    2. M. Krengli, L. Masini, F. Pia
      Pages 129-135
    3. M. Montemurro, J.-Y. Blay, S. Leyvraz
      Pages 137-148
    4. M. Shilkrut, A. Peer, A. Kuten
      Pages 149-157
    5. S. Vieillot, D. Azria
      Pages 159-166
    6. Y. Belkacémi, P. Rouanet, M. Jafari
      Pages 167-173
    7. M. Schlienger, E. Touboul
      Pages 175-182
    8. M. Hübner, N. Halkic, N. Demartines
      Pages 183-194
    9. T. V. F. Nguyen, A.-C. Dupont-Gossart
      Pages 195-206
  5. Genitourinary

    1. Front Matter
      Pages 207-207
    2. M. Ozsahin, A. Zouhair
      Pages 209-213
    3. F. Öner Dinçbaş
      Pages 215-224
    4. C. Durdux, O. Mir
      Pages 225-233
    5. I. Alexandre, E. Horn, F. Selle
      Pages 245-253
    6. A. Zouhair, R. O. Mirimanoff, M. Ozsahin
      Pages 255-259
    7. R.-O. Mirimanoff, A. Zouhair
      Pages 261-267
  6. Gynecological

    1. Front Matter
      Pages 269-29
    2. J. Gligorov, I. Ray-Coquard, P. Pautier, É. Pujade Lauraine, F. Selle, C. Lhommé et al.
      Pages 271-278
    3. C. Nay Fellay, M. Fiche, J.-F. Delaloye, J. Bauer
      Pages 279-292
    4. V. Samouëlian, M.-C. Baranzelli, A. Lesoin
      Pages 293-299
    5. H. Boussen, K. Rahal, N. Bouaouina
      Pages 301-306
    6. H. Lamallem, A. Toledano, P. G. Tsoutsou
      Pages 307-316
  7. Breast

    1. Front Matter
      Pages 329-329
    2. T. Sullivan, A. G. Taghian
      Pages 341-348
    3. K. K. Khanfir
      Pages 349-352
    4. L. Scandolaro
      Pages 353-356
    5. W. Jeanneret Sozzi, R.-O. Mirimanoff
      Pages 357-366
    6. G. Bousquet, J. Bonneterre, Y. Belkacémi
      Pages 367-371
    7. L. Zelek, M. Spielmann, A. Le Cesne
      Pages 373-378
    8. Y. M. Kirova, A. Fourquet
      Pages 379-384

About this book


Why a book dedicated to rare cancer management? Given the large variety of rare cancers,they take up a significant part of our daily practice. Therefore,we owe it to our patients with rare tumours that we use the knowledge gained in the treatment of the more common cancers to provide them with a better future. This knowledge comes from recent developments in molecular diagnostics, systemic treatments with new drugs and targeted therapies together with advanced technologies in the areas of radiology and radiation therapy.
The authors have analyzed the literature and recommend treatments for rare cancers based on results from past studies.We hope that this book will be an aid to those treating rare cancer cases about which, up to now, little has been published, and will reassure our patients that they have not been forgotten.

Yazid Belkacémi is Deputy Head of the Department of Radiation Oncology at the Centre Hospitalo-Universitaire Henri Mondor, Créteil, France. His clinical research interests include the management of breast and gynaecologic cancers, hematologic malignancies, rare tumour management and the development of new technologies in radiation oncology. His biology research topics include radiosensitivity markers in tumours and healthy tissues and combinations of targeted therapies and new drugs with ionising radiation. “As « rarity » is too often synonymous with isolation, it is hoped that this book will contribute to increasing and spreading the knowledge about rare tumours in order to better manage our patients with innovative approaches.“

René-Olivier Mirimanoff is Head of the Department of Radiation Oncology at the Centre Hospitalier Universitaire Vaudois (CHUV) and the University of Lausanne, Switzerland. He is also the founder of the Rare Cancer Network. ( His main research interests are brain tumours and rare cancers. “Rare types of cancer should no longer be considered as orphan diseases.It is time now to gather solid data to guide our medical, radiation and surgical oncology colleagues towards the best possible decisions.“

Mahmut Ozsahin is Deputy Chairman of the Department of Radiation Oncology of the Centre Hospitalier Universitaire Vaudois/University Hospital of Lausanne, Switzerland. His main interests are head and neck cancer, colorectal cancer and haematological malignancies with a special interest in rare tumours in these sites. His biology research topics include radiosensitivity in healthy tissues and predictive assays in radiotherapy. “As no, or very little, prospective clinical research is carried out on rare tumours, it is important to gather and communicate our findings to improve the outcome of our patients.”


breast cancer cancer carcinoma cell diagnostics hematology lymphoma oncology ovarian cancer radiation radiation therapy radiology radiotherapy therapy tumor

Editors and affiliations

  • Yazid Belkacémi
    • 1
  • René-Olivier Mirimanoff
    • 2
  • Mahmut Ozsahin
    • 2
  1. 1.Hôpital Henri-MondorCréteil CedexFrance
  2. 2.Centre hospitalier universitaire VaudoirRue du BugnonLausanneSwitzerland

Bibliographic information

Industry Sectors
Health & Hospitals
Consumer Packaged Goods